1
EMORY UNIVERSITY SCHOOL OF MEDICINE
STANDARD CURRICULUM VITAE FORMAT
Revised: July 25, 2012
1. Heather Lynn Bloom M.D., FACC
2. Office Address: 2A186 Atlanta VAMC, Suite 111B (do not mail)
1670 Clairmont Dr. Decatur, GA 30033
Telephone: 404.321.6111 ex 6391
Fax: 404.329.2211
Home Address: 2120 Starfire Dr. NE
Atlanta, GA 30345 (USE FOR MAIL)
Telephone: 678.919.7197
Fax: 678.919.7198
3. E-mail address: hbloom@emory.edu
4. Citizenship: US birth day & place: 6/26/1969 Long Beach CA
5. Current Titles and Affiliations:
1. Academic appointments:
1. Associate Professor of Medicine, Emory University School of
Medicine, present
2. Assistant Professor of Medicine, Emory University School of
Medicine, July 2005-July 2012
2. Clinical Appointments
1. Director of Clinical Electrophysiology, Atlanta VA Medical
center (VAMC), July 2005-present
2. Staff physician, Atlanta VAMC, and Grady Memorial Hospital,
July 2005-present
6. Licensures/Boards:
1. Medical Licenses
1. ACTIVE: exp 06/11
2. INACTIVE: CA exp 06/04, MA exp.6/1997
2. Medical Boards
1. INACTIVE: Internal Medicine: exp. 12/2010
7. Specialty Boards:
1. Cardiology Board Certification exp 12/2013
2. Cardiac Electrophysiology Board exp 12/2015
8. Education:
2
1. 1987-1991
University of Vermont, Burlington VT
1. BA in Chemistry and English
2. 1989-1990
University of Kent in Canterbury England (jr year
abroad)
3. 1991-1996
University of Vermont College of Medicine
9. Postgraduate Training
1. 1996-1997
General Surgery Internship Berkshire Medical Center,
Pittsfield MA Dr. P Sadighi
2. 1997-2000
Internal Medicine Residency St. Mary’s Medical
Center, San Francisco CA Dr. A Cosintino
3. 2000-2003
Cardiology Fellowship University of California, Davis.
Sacramento CA, Dr. W Bommer
4. 2003-2005
Cardiac Electrophysiology Fellowship, Emory
University Atlanta GA Dr. J Langberg
10. Committee Memberships:
1. National and International:
1. CURRENT
I.
American Heart Association (AHA) Women in Cardiology
Committee for the Council on Clinical Cardiology 2007present
II.
Heart Rhythm Society (HRS) Women’s Leadership
Initiative Task Force 2007-present
III.
HRS Women’s Initiative Committee 2007-present
IV.
American College of Cardiology (ACC) Women in
Cardiology 2005-present
V.
ACC Electrophysiology Committee 2009-present
VI.
Clinical Events Committee (CEC) Board Chair: 20082013; Sponsor: Biotronik. Study: Galaxy: Multicenter
registry (FDA mandated) to record complications of
Biotronik ICD leads. Review cases for complications and
classify per FDA designations. Minimum 2000 patients, 5
years.
VII.
Clinical Events Committee Board Chair: 2008-2013
Sponsor: Biotronik Study: Celestial: Multicenter postapproval registry to record and review complications of
Biotronik left ventricular pacing leads and classify per
FDA designations. Minimum 2000 patients, 5 years
3
VIII.
IX.
2.
Clinical Events Committee Board Chair:2010presentpresent; Sponsor: TyRX Pharma. Study:
Centurion. Multicenter, randomized trial looking at
infection rates in CRT-D recipients after generator
exchange
Clinical Events Committee Board Chair: 2010-present;
Sponsor: TyRX Pharma. Study: Citadel. Multicenter
randomized trial looking at infection rates in ICD
recipients after generator exchange.
PAST
I.
Heart Rhythm Society (HRS) Membership Committee
2007-2009
II.
Clinical Events Committee Board Member 2007-2009.
Sponsor: Biotronik. Study: REPLACE. Multicenter
prospective trial looking at pre-specified complications
rates after cardiac rhythm management device generator
exchanges.
III.
Clinical Events Committee Board Chair 2009-2010
Sponsor: TyRX pharma. Study: COMMAND. Multicenter
retrospective observational study examining infection
rates after cardiac rhythm management device generator
exchanges.
2. Regional and State
I.
Sudden Cardiac Arrest Association (SCAA) – Medical
Advisor for the Greater Atlanta Area 2009-present
a. AED donation ceremony November 2009
b. Annual Meeting April 17, 2010
c. Gwinnett County Summer Safety Fair June 5,
2010 10 am to 3 pm community lectures on SCA
and CPR
d. Community SCA presentation May 20, 2011
e. "Friends and Family" CPR/AED talk to AAHL
(Atlanta adult hockey league) June 2011
II.
Metro-Atlanta Pacing Society (MAPS) 2007-present
a. Annual lectures for EP community
b. Currently undergoing incorporation and 501-C3
status
3. Institutional- Emory University or Atlanta VAMC
4
1. Faculty Life Committee Emory University 2006-present,
secretary 2007-2009
2. Internal Review Board (IRB) Emory University 2007-present
3. Root Cause Analysis Committee VAMC 2007-present
I.
Completed: Committee for faculty Salary Determination
Atlanta VAMC 2006-2007, reconvened 12/2011 for 1
session
11. Manuscript reviewer
1. Medical Journals
1. HEART 2005-present
2. Pacing and Clinical Electrophysiology (PACE) 2005-present
3. Journal of Clinical Electrophysiology (JCE) 2005-present
4. Heart Rhythm 2005- present
5. American Geriatric Cardiology Society 2006- present
6. International Journal of COPD 2007- present
7. Circulation- CIRC EP 2007-present
8. Cardiology Research and Practice 2010-present
9. Combination Products in Therapy
12. Honors and Awards
1. February 2008- VAMC Certificate of Appreciation for VAMC Federal
Women’s Program
2. June 2008- Excellence in Teaching Award from Department of
Medicine Cardiovascular Medicine Fellowship Program
3. June 2009- Excellence in Teaching Award from Department of
Medicine Cardiovascular Medicine Fellowship Program
4. June 2011- Excellence in Teaching Award from Department of
Medicine Cardiovascular Medicine Fellowship Program
13. National and International Society Memberships:
1. American College of Cardiology (ACC): 2001- present
1. ACC Women in Cardiology Section 2005-present
2. Fellow, American College of Cardiology 2006-present
2. Heart Rhythm Society (HRS) 2003-present
3. Electrophysiology Society (EPS) 2006-present
4. American Heart Association (AHA) 2007-present
14. Research Focus: Research interests include risk factors for sudden cardiac
death and atrial fibrillation, including the complex interactions of oxidative
stress with arrhythmia and the relationship of diastolic dysfunction with
arrhythmia. Secondary interests include CRM (cardiac rhythm management)
device infection risk reduction and the relationship between autonomic
dysfunction and arrhythmia.
15. Patents:
5
1. Marker for Arrhythmia Risk: 111828-00156, VA ID#07-129
16. Grant Support:
1. Active Support 8/15/2004 to current
1. Federally Funded: NIH-R01 HL077398, Primary PI Dr. Barry
London. Co-PI for Emory site (2 sites only) Dr. Heather Bloom
Awarded Direct: $446,440. Percent of time: 5% GRADE:
Genetic Risk Assessment of Defibrillator Events. Adult patients
with depressed ejection fraction referred for internal
cardioverter-defibrillator (ICD) placement will undergo 5+ year
follow up for arrhythmia events and provide DNA samples for
multiple evaluations of polymorphisms that lead to increased
risk of arrhythmias. Inclusive dates: 2007-2012 (follow up will
continue past funding; application for additional NIH grant
funding by primary site is currently undergoing revisions)
2. Private foundation funded
I.
TyRX Pharmaceuticals: Sponsor two multicenter trials: I
am the site PI for Atlanta VAMC. VA contract for
payment per visit.
a. Centurion: inclusive dates: 2009 to current
(predicted 2013): Prospective observational trial
examining the Aigis™ antimicrobial envelope
effects on cardiac rhythm management device
infections in Cardiac Resynchronization Therapy
(CRT) devices. Contract: $5265 Percent of
time:1%
b. Citadel: inclusive dates 2009 to current (predicted
2013): Prospective observational trial examining
the Aigis™ antimicrobial envelope effects on
cardiac rhythm management device infections in
Internal-Cardioverter Defibrillator (ICD) infections.
Contract $5265 Percent of time: 1%.
c. Sorin Group (ELA Medical). OPTION:2008-2011
Multicenter trial, I am the site PI for Atlanta VAMC.
VA contract for payment per visit. Do ICD patients
benefit from dual chamber ICD therapycomparing ICD therapies with the PARAD
algorithm. Contract: $3592. This study is in the
process of being closed out.
2. Prior Support
1. Emory University Research Committee (URC): Award
amount: $30,000 Personal Grant for me, PI. Percent of time,
2% July 2007-June 2008. Observational clinical study
examining co morbidities for mortality in ICD patients. (See CV,
publication # 13 )
6
2. Grant- Pfizer Pharmaceuticals. Award Amount: $75,000. Dr.
Samuel Dudley, PI, Dr. Heather Bloom, Co-PI 2006-2010. (Sole
PI after Dr. Dudley departed 2007) Single center trial.
Atorvastatin Therapy for the Prevention of Atrial fibrillation
(STOPAF) published 12/2010 (See CV publication # 12);
Percent of time 2%.
3. Education Grant: 2007. $10,000. Sponsor: St. Jude Medical.
This was an unlimited educational grant designed to support EP
training for fellows and staff entirely at my discretion. Funds
have been allocated to date for EP textbooks and educational
conferences.
4. RIGHT (Rhythm ID Going Head To Head) – Boston
Scientific, Multicenter trial. Co-PI, site PI for Atlanta VAMC.
Assessed arrhythmia discrimination in Guidant and Medtronic
devices. Completed 2008. Funds went to Dr. Zafari; do not have
data on award amount. Percent of time 1%.
17. Clinical Service Contributions 2005-Present
1. Electrophysiology consult service:- 12 months per year
2. General Cardiology consult service:1.5 months per year
3. Cardiac Intensive Care Unit: 1.5 months per year
4. Electrophysiology Clinics: 4 - ½ day clinics per week
5. Pre-ICD clinic: ½ day per week
6. Pacer/ICD clinic: 3 days per week
7. Invasive procedures/surgeries: 4 days per week (3.5 days VAMC, 1
day Grady Hospital)
8. Non-invasive procedures (cardioversions, tilt table tests): 1-4 per week
18. Formal Teaching
1. General recurrent teaching: 2005 - present
1. House staff: formal lectures for residents, fellows, medical
students during service months
2. Clinical Cardiology Fellow: a series of 3 formal talks per
week, 12 months a year
3. VA cardiology Fellow weekly noon conference: EGC for the
boards, Monday 12-1 pm
4. VA house staff noon conference: SVT or VT or Devices, 2-5
x per year
5. Atlanta VAMC staff conferences: ECG and arrhythmia q. o.
month
2. Medical Student Teaching (formal lectures):
1. Emory University Cardiology Series: Arrhythmia April 6,
2009
7
2. Emory University Cardiology Series: Arrhythmia April 5,
2010
3. Emory University Cardiology Series: Arrhythmia April 4,
2011
3. Residents/ House Staff
1. Grady Clinical Core Lecture Cardiology- Ventricular
Tachycardia 3/10/2005
2. VA Clinical Core Lecture Cardiology- Ventricular
Tachycardia 3/22/2005
3. Grady Grand Rounds- Cardiac Rhythm Management
Devices 11/10/2005
4. Grady Clinical Core Lecture Cardiology- Ventricular
Tachycardia 3/09/2006
5. VA Clinical Core Lecture Cardiology- Ventricular
Tachycardia 3/10/2006
6. Grady Grand Rounds- Cardiac Rhythm Management
Devices 9/7/2006
7. VA Clinical Core Lecture Cardiology- Ventricular
Tachycardia 3/2007
8. Grady Clinical Core Lecture Cardiology- Supraventricular
Tachycardia 4/3/2007
9. VA Clinical Core Lecture Cardiology- Supraventricular
Tachycardia 4/10/2007
10. Grady Grand Rounds- Cardiac Rhythm Management
Devices 9/6/2007
11. VA Clinical Core Lecture Cardiology- Ventricular
Tachycardia 2/28/2008
12. Grady Grand Rounds- Cardiac Rhythm Management
Devices 8/28/2008
13. VA Clinical Core Lecture Cardiology- Wide Complex
Tachycardia 4/7/2009
14. Grady Grand Rounds- Cardiac Rhythm Management
Devices 8/27/2009
15. ENT surgical residents Grand Rounds: Atrial fibrillation
6/14/2010
16. Grady Grand Rounds- Cardiac Rhythm Management
Devices 10/28/2010
17. VA noon conference- Atrial Arrhythmias and Ablation
10/29/2010
18. Clinical Core VA lecture house staff: Electrocardiograms
8/23/2011
4. Cardiology Fellows
1. General Cardiology Fellows Core Lecture: Syncope
3/21/2007
8
2. General Cardiology Fellows Core Lecture: Supraventricular
arrhythmias 9/8/2008
3. General Cardiology Fellows Core Lecture: Supraventricular
arrhythmias 9/8/2008
4. General Cardiology Fellows Core Lecture: Supraventricular
arrhythmias 10/2/2009
5. General Cardiology Fellows Core Lecture: Ventricular
arrhythmias 12/7/2009
6. General Cardiology Fellows Core Lecture: Syncope
11/3/2010
7. General Cardiology Fellows Core Lecture: Bradycardia
10/17/2011
8. General Cardiology Fellows Core Lecture: Syncope
12/17/2011
5. Other Local
1. Electrophysiology Journal Club Emory University School of
Medicine 8/15/2007 REPLACE study
2. ICD support group for Veterans: Atlanta VAMC 6/2007ongoing meets every 4-8 weeks with topics and discussion for
patients
6. National and International
1. Invited Physician Panel Discussion: Hospital Acquired
Infections: HRS Denver CO 5/13/2010
2. LIVE Webinar, Cardiac Rhythm Management Device
Infections; presented online and recorded 6/21/2010
3. Update on Device Infections: TyRX Pharma, presented
during HRS scientific sessions May 6, 1 pm
19. Supervisory Teaching:
1. Residency program per above
2. Other Mentoring:
1. Premedical students:
I.
Summer intern 2011: Jesus Arroyo
II. Summer intern 2012: Jessica Parker
2. Medical Student Summer Intern: William Jang, Summer
2006, resulted in American College of Cardiology Oral Abstract
Presentation
3. Lisa Williams, RN 2007-2010 mentored involving research,
resulted in Lisa’s participation on several research studies, and
two publications in EP Lab Digest (Peer reviewed publication
not listed on PubMed: CV citations # 27 B, C)
4. Clinical Research Coordinators
9
I.
Irfan Shukrullah MD, 2006-2008 now in Internal Medicine
(IM) residency University of Il at Chicago, applying for
cardiovascular fellowship. Multiple abstract publications
II. Radihka Gadesam MD, 2007-2009, now in IM residency
Morehouse College of Medicine
III. Ravindar Reddy MD 2007- present (multiple abstracts
and manuscripts accepted as a trainee for 2 programs)
5. Fellows:
I.
Samantha Svarczkopf MD, 2006-2007 Cardiology Fellow,
EP fellowship University of Louisville 2009-2011
Columbus Regional Hospital, Indiana
II. Richard Vest MD, 2007-2009, Cardiology Fellow, EP
fellowship MSSC 2009-2011. Upstate Cardiology,
Greenville SC
20. Lectureships, Seminar Invitations and Visiting Professorships:
1. External Invited Lectures
1. Birmingham VAMC: Electrophysiology Studies: 6/19/2006
2. Cognis-Teligen educational lecture for Allied Professionals
8/18/2008
3. South Atlantic Society for Allied Professionals: End of Life
issues with Cardiac Rhythm Management Devices September
2011
4. Women in Electrophysiology 2011; Annual conference for
women in electrophysiology. Invited faculty speaker case
presentations September 2011
2. University Sponsored CME Courses
1. Emory University IM board review course (Annual); 20062011
2. Emory Crawford-Long Hospital Management Course: Rate
Control of Atrial Fibrillation April 20, 2007
3. Heart Failure Management Symposium 2008 (Morehouse
School of Medicine) Debate: Implant ICDs in all Heart Failure
Patients according to LV Ejection Fraction Only: Protagonist.
Panel Discussion on Heart Failure
21. Other Activities
1. Other Teaching:
1. Lecturer, Fellows Conference, Dates. Prepared and
presented multiple lectures and accompany visual materials at
monthly fellows conferences. (Titles listed on teaching portfolio.)
2. Formal Hospital Protocols Written:
1. Protocol for Use of IV beta-blockers on telemetry 2007
2. Protocol for CRM Device Deactivation 2007
3. Protocol of initiation of Dofetilide 2008
10
4. Protocol for use of Precidex 2010
3. Consultant:
1. New Mentor, 6/2010 to present Reviewed and edited clinical
management and treatment guidelines on the following topics
for use by hospitalists and house staff:
I.
Aortic Stenosis: June 2010
II. Aortic Regurgitation: October 2010
III. Ventricular Fibrillation: April 2011
IV. Cholesterol Guidelines for Patients: July 2011
V. Post-operative atrial fibrillation: August 2011
VI. Post-PCI guidelines: August 2011
22. Bibliography:
1. Published and accepted Research Articles (clinical, basic science,
other) in peer reviewed refereed journals:
1.
Sabapathy R, Bloom HL, Amsterdam EA. Right precordial and
posterior chest leads do not increase detection of positive
response in electrocardiogram during exercise treadmill testing.
Am J Cardiol. 2003 Jan 1;91(1):75-7. PubMed PMID: 1205576.
2.
Bloom H, Glatter K. Arrhythmia of the month by Kriby et al.
Cardiovasc Electrophysiol 2002 Jul;13(7):732; author reply
732.PubMed PMID:12139303
3.
Bloom H, Chiamvimonvat N, Whitcomb C, Glatter K. Malignant
vasovagal syncope. Circulation. 2003 June 17;107(23)2987-8.
PubMed PMID: 12814986
4.
Bloom H, Heeke B, Leon A, Mera F, DeLurgio D, Beshai J,
Langberg J; Chronic Renal Insufficiency and the Risk of Infection
from Pacemaker or Defibrillator Surgery. Pacing
ClinElectrophysiol. 2006 Feb; 29(2):142-5. PubMed PMID:
12814986
5.
Bloom H, Shukrullah I, Cuelar J, Lloyd M, Dudley Jr, S, Zafari M,
Long-term survival after Successful In-hospital Arrest
Resuscitation. Am Heart J. 2007 Mayl153(5):831-6. PubMed
PMID: 16492298
6.
Neuman R, Bloom HL (co First Authors), Shukrullah I, Darrow
LA, Kleinbaum D, Dudley SC. Oxidative Stress markers are
associated with persistent atrial fibrillation. Clinical Chemistry
June 28, 2007:53;1652-57 PubMed PMID: 17452161
7.
Endeshaw YW, Bloom HL, Bliwise DL. Sleep disordered
breathing and Cardiovascular disease in the Bay Area Sleep
Cohort. Sleep 2008 April 31(4):563-568 PubMed PMID:
17599958
8.
Ali B, Bloom HL, House D, Veledar E, Norval R, Dudley SC,
Zafari AM. Automated External Cardioversion Defibrillaton
Monitoring in Cardiac Arrest: A Randomized Trial. Trials 2008
9:36. PubMed PMID: 18523216
11
9.
10.
11.
12.
13.
14.
15.
Bloom HL; Shukrullah I, Cuellar J, Veledar E, Gutmann R,
London B, Dudley jr. SC. Statins Decrease Oxidative Stress and
ICD Therapies. Cardiol Res Practic. 2010; 2010:253803. Epub
2010 Mar 25. PubMed PMID: 20369058.
Bloom HL Constantin L, Dan D, De Lurgio DB, El-Chami M,
Ganz LI, Gleed KJ, Hackett FK, Kanuru NK, Lerner DJ, Rasekh
A, Simons GR, Sogade FO, Sohail MR. Incidence of Implantation
Success and Infection in Cardiovascular Implantable Electronic
Device Procedures with the Aigis rx Anti-bacterial Envelope.
Pacing Clin Electrophysiol. 2011 Feb; 34(2): 133-42. doi:
10.1111/j.1540-8159-2010.02931.x.Epub 2010 October 13.
PubMed PMID: 20942819
Shukrullah I, Jang W, Vest RN, Dudley SC, Bloom HL. Left
Atrial Enlargement Correlates with Inflammation and Oxidative
Stress in Patients at HighRisk for Atrial Fibrillation. Journal of
Clinical and Experimental Cardiology. August 29, 2010 PMID
Negi S; Shukrullah I; Veledar E; Bloom HL; Jones D; Dudley S;
Statin Therapy for the Prevention of Atrial Fibrillation Trial (SToP
AF trial). J Cardiovasc Electrophysiol. 2011 Apr;22(4):414-9. doi:
10.1111/j.1540-8167.2010.01925.x. Epub 2010 Oct 13. PMID:
20946227
Vest RN, Gadesam RR; Wijayawardana SR; Valadri RR; Zafari
M; Easley K; Bloom HL. Association of Elevated Body Mass
Index with Appropriate ICD Therapy in a Veteran Patient
Population with Heart Failure and Implantable CardioverterDefibrillators. The Journal of Innovations in Cardiac Rhythm
Management, 2 (2011), 512–518.
Refaat MM; Lubitz SA; Makino S; Islam Z; Frangiskakis MF;
Mehdi H; Gutmann R; Zhang ML; Bloom HL; MacRae CA;
Dudley SC; Shalaby AA; Weiss R; McNamara DM; London
B;Ellinor PT. Genetic Variation in the Alternative Splicing
Regulator, RBM20, is associated with Dilated Cardiomyopathy.
Heart Rhythm. 2011 Oct 17 [Epub ahead of print] PubMed PMID:
22004663
Blanco RR; Austin H; Vest RN; Valadri R; Li W; Lassegue B;
Song Q; London B; Dudley SC; Bloom HL; Zafari AM. The
Association of ACEI/D genotype and AT1-A1166C polymorphism
with implantable cardiac defibrillator interventions in patients with
heart failure. ACCEPTED: Journal of Heart Failure July 2012
2. Manuscripts submitted, under review
1. Blanco RR, Amer M; Darrow LA; Bloom HL; Dudley SC MS
TITLE: A Predictive Model of Postoperative Atrial Fibrillation with
Cardiothoracic Surgery resubmitted World Journal of
Cardiovascular Medicine 11/2011
12
2.
Bloom HL. A novel technique for avoiding venoplasty during
totally occluded subclavian or SVC veins during cardiac rhythm
management device implantation Submitted: Heart Rhythm
(12/2011)
3.
Valadri R; Veledar E; Mengistu A; Gadesam R; Bali C; Wood C;
McIlraith T; Ginn K; Kohler S; McCall S; Hamilton S; Onwuanyi
A; Bloom HL; El Chami M; Delurgio DB. The Association of High
Risk Berlin Score with Nocturnal Sudden Cardiac Death in
Systolic Heart Failure Patients with Implantable Cardioverter
Defibrillator: Submitted for Young Investigator Award Heart
Rhythm Society Annual Scientific Sessions 2012
3. Invited Editorials
1. Bloom, H.L. Concise review of atrial fibrillation: treatment update
considerations in light of AFFIRM and RACE. Clin Cardiol. 2004
Sep;27(9):495-500. PMID: 15471159
2.
Bloom HL Beyond Beta-blockade: nerve growth factor and
arrhythmia. Heart Rhythm, 2007 Sept;4(9):1214-5 2007 July 4
PMID 1776567
4. Review Articles
1. Bloom HL Differential Entrainment Pacing, two great paces that
pace great together. Heart Rhythm 2009 April:6(3):501-2 PMID
19324310
2. Bloom HL Treatment of Ventricular Tachycardia, consider
ablation sooner. F1000 Medicine Reports 2009, 1:71 PMID
20948708
3. Jordan RJ; Bloom HL Prevention of bacterial infections in
patients with cardiac implantable devices; old traditions meet new
technology. The Journal of Innovations in Cardiac Rhythm
Management 1 (2010):63-71
5. Abstracts:
1.
Glatter KA; Ackerman MJ, Van Hare GF; Bloom H; Dorostkar
PC, Scheinman MM. Type and reproducibility of symptoms in a
genotyped congenital Long QT patients. JACC 2002:39
(supplement A):117A
2.
Sabapathy R; Bloom H; Lewis W; Amsterdam E. Right
Precordial and posterior chest leads do not augment detection
of ischemia in the exercise electrocardiogram. Circulation
Supplement (104);3474, 2001
13
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
Bliwise DL; Bloom HL; Endeshaw YE; Ansari FP. Sleep Apnea
and Cardiovascular disease in the Bay Area Sleep Cohort.
AGS 2004
Bloom HL; Langberg JJ Preoperative BNP levels Correlate with
Degree of Fractional Improvement in Hall walk in Patients
undergoing Cardiac resynchronation therapy (CRT). JACC
2005:45 (Supplement B1);321B
Bloom H; Heeke B; Leon A; Mera F; De Lurgio D; Beshai J,
Langberg JJ. Renal Insufficiency, a potent and previously
unrecognized risk for infection after device implantation. Heart
Rhythm 2005:4(5s)
Newman RB; Bloom HL; Darrow LA; Kleinbaum D; Dudley jr.
SC; Oxidative Stress but not inflammatory markers predict
persistent atrial fibrillation. Heart Rhythm May 2006: 3(5):S3023
Jang W; Dudley jr. SC; Bloom HL; Left Atrial Enlargement
Correlates with Inflammation and Oxidative Stress in Patients at
high risk for atrial fibrillation. JACC 2007:49(9) Supplement
A;819-7
Jackson C; Ali B; Bloom H; Zafari AM; Automatic External
Cardiac Defibrillation Monitoring in cardiac Arrest. Presented J
Willis Hurst Internal Medicine Residency Program Annual
Research Day, Emory University School of Medicine 1/18/2007.
Bloom H; Shukrullah I; Cuellar J; Lloyd M; Dudley SC; Zafari
AM. Long term survival after in-hospital cardiac arrest. Heart
Rhythm 2007:4(5S) p03-7
Ali B; Bloom H; Veledar E; Norval R; Dudley jr. SC; Zafari AM.
Automated External Cardioversion Defibrillation Monitoring in
Telemetry (moderated poster session, Best Original
Resuscitation Science). Circulation, Oct 2007; 116: II_927.
Shukrullah I; Cuellar J; Veledar E; Bloom H; Dudley jr. SC.
Plasma Redox state and the recurrence of atrial fibrillation.
JACC March 11, 2008; 51: A1-A34
Bloom HL; Shukrullah I; Cuellar J; Veledar E; Guttmann R;
London B; Dudley jr. SC. Statins decrease oxidative stress and
ICD events. Heart Rhythm 45(5) S May 2008.
Bloom HL; Fan TM Using Ventricular Sense Response™ to
optimize Biventricular Pacing in a patient with no atrial lead.
Heart Rhythm 5(5S) May 2008.
Ali B; Vest RN; Bloom HL; Veledar E; House D, Norvel R,
Dudley SC jr; Zafari AM. Automated External
Cardioversion/Defibrillation Monitoring in telemetry Patients:
Poster presentation 14th World Conference on Heart Disease
July 2008. Published online:
http://www.cardiologyonline.com/wchd08/final_prog_sun.htm
14
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
Fangiskakis J; Niles K; Grimley S; Guttmann R; Bloom HL;
Dudley SC; Ellinor P; Shalaby A; Weiss R; Saba S; MacNamere
A. African-Americans with Congestive Heart Failure have more
arrhythmias than Caucasians independent of the SCN5A
S1103Y Genotype. Circulation 2008;118:S_718.
Vest RN; Bloom HL. African-Americans with Nonischemic
cardiomyopathy have more ventricular arrhythmias than
Caucasians and have higher levels of inflammatory and
oxidative stress markers. ACC GA Chapter Annual Scientific
Sessions, November 22, 2008
Vest RN; Gadesam R; Valadri R; Bloom HL. Obesity does not
increase risk of ventricular arrhythmias in a veteran patient
population with ICDs. Keystone Symposium: Feb 25, 2009
Vancouver BC
Vest RN; Gadesam R; Valadri R; Bloom HL; Effect of Gender
on Patients with systolic heart failure: women have more
ventricular arrhythmias than men. JACC 2009;53:A136
Refaat M; Frangiskakis JM; Grimley S; Gutmann R, Bloom HL;
Dudley SC, Ellinor P; Shalaby A; Weiss R; McNameara D;
London B. The β2-Adrenergic Gln27 polymorphism is
associated with increased ventricular arrhythmias in patients
with severe heart failure (moderated poster session) May 15,
2009. Heart Rhythm vol. 6(5S): MP 02-01
Bloom HL; Vest RN; Blanco R; Valadri R: Shukrullah I;
Gutmann R; London B; Dudley SC, Zafari AM. AfricanAmericans with cardiomyopathy have more ventricular
arrhythmias than Caucasians and have higher levels of
inflammatory and oxidative stress markers (Oral Presentation).
Heart Rhythm 6(5S) May 2009 S16-7
Vest RN; Blanco RR, Valadri RR, Gutmann R; Dudley SC;
London B, Zafari AMl; Bloom HL; African Americans with Heart
Failure, Racial differences in ICD therapies and inflammatory
and oxidative stress markers. European Society of CardiologyHeart Failure Annual Scientific Sessions; Nice, France; May 30,
2009.
Vest RN; Blanco RR: Valadri RR; Gutmann R; Dudley SC;
London B; Zafari AM; Bloom HL; Influence of elevated BMI on
ventricular arrhythmias in a veteran patient population with heart
failure and internal cardioverter-defibrillators. European Society
of Cardiology- Heart Failure Annual Scientific Sessions; Nice,
France; May 30, 2009.
Lerner D; Bloom HL; Constantin L; Delurgio DB; Hackett K;
Kanuru NK; Rasekh A; Sogade FO. Aigis Rx Anti-bacterial
envelope retrospective registry results. TCT Sept 22, 2009.
Blanco RR: Vest RN; Valadri R; Li W; Austin H; Song Q; Dudley
SC; London B; Bloom HL; Zafari AM. The relationship
15
25.
26.
27.
28.
29.
30.
31.
32.
33.
between the AGTR1-A1166C polymorphism with implantable
cardiac defibrillator therapies in patients with chronic heart
failure Circulation. 2009;120:S1468.
Mehdi H; Frangiskakis JM; Grimley S; Gutmann R; Bloom HL;
Dudley SC, Ellinor PT; Shalaby A; Weiss R; Saba S; McNamara
DM; London B. NOS1AP is associated with arrhythmias in a
heart failure population with severe LV dysfunction Circulation.
2009;120:S571-2.
Aleong RG, Halder I, Bloom HL, Dudley SC, Ellinor PT, Saba S,
Shalaby A, Weiss R, London B. 2010. Left Ventricular Dilatation
Increases the Risk of Ventricular Arrhythmias [Abstract]. Heart
Rhythm. Vol. 7, no. 5, Supplement: S427
Valadri R; Bloom H; Gadesam R; Delurgio D; Jones D;
Bhadriraju S. Obstructive Sleep Apnea is associated with
worsened oxidative stress and treatment resistance in atrial
fibrillation. Journal of Cardiac Failure 16(8) S1: S61 August
2010.
Valadri RV; Gadesam R; McLraith T; Onwuanyi A; Bloom HL;
Delurgio DB. Diastolic Dysfunction can predict ventricular
arrhythmias in Sarcoidosis. Emory University, September 2010
Bavikati VV; Jordan JR; Manocha P; Langberg JL; Vest RN;
Bloom HL; Lloyd MS. Underlying coronary artery disease
potentiates the antiarrhythmic effect of dofetilide on atrial
fibrillation. JACC 2010; 55;A8.E80.
Refaat M; Mehdi H; Halder I; Islam Z ;Friehling M; Liu J;
Gutmann R; Bloom HL ; Dudley SC; Ellinor P, Shalaby AA;
Weiss, R; Saba S; McNamara DM; London B. Variations in
Cardiac Calcium-Handling Genes are Associated with
Ventricular Arrhythmias in Patients with Severe Cardiomyopathy
presented: Heart Rhythm Society, May 4, 2011.
Valadri R; Gadesam R; Bali C; McIlwraith R; Onwuanyi A;
Delurgio D, Bloom H. Cardiac Sarcoidosis presenting as
cardiac dyssynchrony and failure of cardiac resynchronization
therapy. JMCC 51(3): S20; September 2011.
Valadri R; Gadesam R; Bloom H; Olatidoye A; Onwuanyi A.
Heart Failure with preserved ejection fraction complicating
peripartum; phenotypic variant of peripartum cardiomyopathy.
JMCC 51(3): S30; September 2011.
Refaat MM; Benhayon D; Batal O; Purohit A; Halder I, Mehdi H,
Gutmann, R; El Masry H; Bloom HL; Dudley SC; Ellinor PT;
Shalaby AA; Weiss R; McNamara D, Saba S; London B.
Fragmented Wide QRS on a 12-Lead Electrocardiogram
Increases the Risk of Ventricular Arrhythmias in Patients with
Severe Systolic Dysfunction. Presentation: , American Heart
Association Annual Scientific Sessions; November 13, 2011.
16
34.
35.
36.
37.
38.
Dai S; Mehdi H; Halder I; Singh M; Gutmann R; Bloom HL;
Dudley SC; Ellinor PT; Shalaby A; Weiss R; Nerbonne JM;
London B; Splice Site Insertion in FGF12 is Associated with
Ventricular Arrhythmias in Heart Failure Patients. Presentation:
American Heart Association Annual Scientific Session;
November 14, 2011.
Valadri R; Veledar E; Gadesam R; Cross JA; Cardona S,
Strayhorn G; Bloom HL; Delurgio DB; Butler J; Ofili E; Onwuanyi
A. Is there a mortality benefit with Renin-Angiotensin System
( RAS) inhibition in African Americans (AA) with heart failure with
preserved ejection fraction (HFPEF)? Accepted for American
College of Cardiology Annual Scientific Sessions March 2012,
Chicago IL
.Valadri R; Veledar E; Gadesam R; Cross JA; Cardona S,
Strayhorn G; Bloom HL; Delurgio DB; Butler J; Ofili E; Onwuanyi
A. Effect of Angiotensin Receptor Blocker (ARB) therapy on long
term survival in African Americans (AA) with Heart Failure (HF)
Accepted for American College of Cardiology Annual Scientific
Sessions March 2012, Chicago IL
Valadri R; Veledar E; Gadesam R; Cross JA; Cardona S,
Strayhorn G; Bloom HL; Delurgio DB; Butler J; Ofili E; Onwuanyi
A. The Association of High Risk Berlin Score with Nocturnal
Sudden Cardiac Death in Systolic Heart Failure Patients with
Implantable Cardioverter Defibrillators Accepted for Heart Rhythm
Society Annual Scientific Sessions May 9-12 2012
Valadri R; Veledar E, Gutmann R; Bloom HL; Dudley SC London
B "Evidence for the Disparity in Implantable Cardioverter
Defibrillator Efficacy in Patients above 60 Years and below 60
Years" has been accepted for presentation at the 16th Annual
Scientific meeting of the Heart Failure Society of America
(September 9-12, Washington State Convention Center, Seattle,
WA).- ACCEPTED
23. Symposium contributions:
1. Heart Failure Management Symposium 2008, Morehouse School of
Medicine Debate: Implant ICDs in all heart failure patients according to
LVEF only; Panel Discussion
24. Manuals, videos, computer programs and other teaching aids
1. Clinical Electrophysiology Manual for EP staff (80 pages) 2006
2. What You Should Know About Your Defibrillator (patient hand out; 7
pages) 2007
3. Basics for the ICD patient (ppt talk) 2007
4. What you should know about your Defibrillator: DVD for patients with
cardiology staff 2007
17
5.
6.
7.
8.
9.
EP and ECG questions for Cardiology Fellows Inservice Exam, 2008;
EP and ECG questions for Cardiology Fellows Inservice Exam 2009;
EP and ECG questions for Cardiology Fellows Inservice Exam 2010;
EP and ECG questions for Cardiology Fellows Inservice Exam 2011;
Cardiac Rhythm Management and device infections in the modern era
2011
25. Other presentations
1. Comparison of Markers of Oxidative Stress Present in Left Atrial
Appendage Tissue from Subjects With and Without Atrial Fibrillation”
Irfan Shukrullah MBBS; Heather L. Bloom MD; Thomas Vassiliades
MD; Jonathan Langberg MD; David Vega MD; David Harrison MD;
Samuel Dudley MD, PhD. . Poster Presentation at EMORY University
3/17/2006.
26. Other Publications:
1. Bloom HL: Interview with ?. Strategies for Preventing Cardiac Device
Implant Infections: Interview with Heather Bloom, MD. EP Lab Digest
12/03/2009.
2. Williams L; Bloom HL. Moderate Sedation Pioneers for Atrial
Fibrillation Ablations EP Lab Digest 9/10/2010
3. Bloom HL. Clinical and Industrial News. EP Lab Digest 5/2/2010
27. Letters To The Editor
1. Bloom, H, Glatter, K. J Arrhythmia of the month by Kirby et al.
J Cardiovasc Electrophysiol. 2002 Jul;13(7):732; author reply 732.
28. Presentations at National/International Conferences
1. Oral Presentation HRS 2005: Bloom H Renal Insufficiency: A Potent
and Previously Unrecognized Risk for Infection after Device
Implantation
2. Poster Presentation ACC 2005: Bloom H: Preoperative BNP Levels
Correlate with Degree of Fractional Improvement in Hall walk in
Patients Undergoing Cardiac Resynchronization Therapy (CRT)
3. Oral Presentation HRS 2007. Bloom H Long Term Survival After InHospital Cardiac Arrest
4. Poster Presentation HRS 2008: Bloom H Statins Decrease Oxidative
Stress and ICD Events
5. Poster Presentation HRS 2008: Bloom H Using Ventricular Sense
Response™ to optimize Biventricular Pacing in a Patient with no Atrial
lead
6. Oral presentation European Society of Cardiology Heart Failure Annual
Scientific Session, Nice France Vest RN, Bloom H African Americans
with Heart Failure, Racial Differences in ICD Therapies and
Inflammatory and Oxidative Stress Markers
7. Oral Presentation HRS 2009. Bloom H African-Americans with
Cardiomyopathy Have More Ventricular Arrhythmias than Caucasians
18
and Have Higher Levels of Inflammatory and Oxidative Stress Markers
Genetic Syndromes in SCD: Brugada and Other Factors
8. Oral Presentation HRS 2009. Gleva MJ for the REPLACE
investigators: Complication Rates Associated with Pacemaker and
Implantable Defibrillator Generator Replacement: Results from the
REPLACE Registry: Late Breaking Clinical Trials Thursday, May 14,
2009, 10:30 a.m. - 12:00 p.m
9. Oral Presentation TCT 2009: Bloom H AIGISRx Anti-bacterial
Envelope Retrospective Registry Results
10. Oral Presentation HRS 2011: Bloom H CRMD infections, old
techniques meet new technology
29. Online, Peer Reviewed Electronic Publications
1. Bloom HL. Severe dyspnea on exertion. Cardiosource Web Site,
American College of Cardiology Foundation and Elsevier, Inc. July
2003.
http://www.accardio.org/cs/casestudies/initPres.asp?studyID=381. July
16, 2003
2. Bloom, HL Faculty of 1000 Medicine, 29 May 2008
http://www.f1000medicine.com/article/id/1108934
3. Bloom, HL Faculty of 1000 Medicine, 26 August 2008
http://www.f1000medicine.com/article/id/1119287
4. Bloom, HL Faculty of 1000 Medicine, 17 October 2008
http://www.f1000medicine.com/article/id/1124221
5. Bloom, HL Faculty of 1000 Medicine, 16 January 2009
http://www.f1000medicine.com/article/id/1148137
6. Bloom HL Faculty of 1000 Medicine, 19 April 2009
http://www.f1000medicine.com/article/id/1158807
7. Bloom HL: Faculty of 1000 Medicine, 9 Nov 2009
http://www.f1000medicine.com/article/id/1163698/evaluation
8. Bloom HL: Faculty of 1000 Medicine 6 Jan 2010
http://f1000medicine.com/article/id/1347963/evaluation
9. Bloom HL: Faculty of 1000 Medicine 17 Feb 2010
http://www.f1000medicine.com/article/id/1968975/evaluation
10. Bloom HL: Faculty of 1000 Medicine X May 2010
http://www.f1000medicine.com/article/id/3185964/evaluation
11. Bloom HL: Faculty of 1000 Medicine 9 July 2010
http://www.f1000medicine.com/article/id/3900956/evaluation
12. Bloom HL: Faculty of 1000 Medicine 15 November 2010
http://f1000.com/6119956
13. Bloom HL: Faculty of 1000 Medicine 7 February 2011
http://f1000.com/8159959
14. Bloom HL: F1000 23 June 2011 http://f1000.com/11466957
15. Bloom HL: F1000 11 October 2011 http://f1000.com/13357297
16. Bloom HL: F1000 19 January http://f1000.com/13474956
17. Bloom HL: F1000 14 April 2012. http://f1000.com/14264112
19